ARTICLE | Clinical News
Labazenit budesonide/salmeterol regulatory update
March 25, 2013 7:00 AM UTC
EMA's CHMP issued a negative opinion against approval of Laboratoire's Labazenit budesonide/salmeterol to treat asthma in adults requiring a combination product containing an inhaled corticosteroid an...